Concerns About Using hCG in Animal Models for Cancer Research
Author Information
Author(s): R.K. Iles
Primary Institution: Joint Academic Departments of Obstetrics, Gynaecology and Reproductive Physiology, St. Bartholomew's Hospital Medical College
Hypothesis
The protective effects of chorionic gonadotrophin (CG) in mammary carcinogenesis in rats may be flawed due to species differences in hormone expression.
Conclusion
The study's conclusion that hCG has protective effects against tumor formation in rats is likely incorrect due to the absence of the beta-CG gene in these animals.
Supporting Evidence
- Rats do not possess the CG specific beta-subunit gene, which undermines the study's conclusions.
- Pregnancy hormones in lower mammals function differently than in primates, suggesting alternative mechanisms for tumor protection.
- The protective effects observed may be due to stimulation of gonadal LH receptors rather than hCG.
Takeaway
The study suggests that a hormone called hCG might help prevent cancer in rats, but the author argues that this idea is wrong because rats don't have the right version of this hormone.
Potential Biases
The author suggests that the original study may have been misled by unsubstantiated claims.
Limitations
The study's reliance on a hormone not present in the species used raises questions about its validity.
Participant Demographics
The commentary discusses research conducted on virgin immature Sprague-Dawley rats.
Want to read the original?
Access the complete publication on the publisher's website